Tg Therapeutics (TGTX) Capital Expenditures Growth (3y) (2015 - 2025)
Tg Therapeutics (TGTX) Capital Expenditures Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 181.61% |
| Sep 30, 2025 | 171.44% |
| Mar 31, 2025 | 52.86% |
| Dec 31, 2024 | -35.97% |
| Sep 30, 2024 | -32.78% |
| Dec 31, 2022 | -55.48% |
| Sep 30, 2022 | -60.52% |
| Mar 31, 2022 | -20.63% |
| Dec 31, 2021 | 137.13% |
| Sep 30, 2021 | 44.84% |
| Jun 30, 2021 | 72.66% |
| Mar 31, 2021 | 40.81% |
| Dec 31, 2020 | -1.86% |
| Sep 30, 2020 | 36.49% |
| Jun 30, 2020 | 182.31% |
| Dec 31, 2019 | 184.47% |
| Sep 30, 2019 | 134.18% |
| Jun 30, 2019 | 6.60% |
| Mar 31, 2019 | 66.57% |
| Dec 31, 2018 | 33.01% |